These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9916797)

  • 1. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.
    Nezu J; Tamai I; Oku A; Ohashi R; Yabuuchi H; Hashimoto N; Nikaido H; Sai Y; Koizumi A; Shoji Y; Takada G; Matsuishi T; Yoshino M; Kato H; Ohura T; Tsujimoto G; Hayakawa J; Shimane M; Tsuji A
    Nat Genet; 1999 Jan; 21(1):91-4. PubMed ID: 9916797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency.
    Mayatepek E; Nezu J; Tamai I; Oku A; Katsura M; Shimane M; Tsuji A
    Hum Mutat; 2000 Jan; 15(1):118. PubMed ID: 10612840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine transport by organic cation transporters and systemic carnitine deficiency.
    Lahjouji K; Mitchell GA; Qureshi IA
    Mol Genet Metab; 2001 Aug; 73(4):287-97. PubMed ID: 11509010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
    Wang Y; Kelly MA; Cowan TM; Longo N
    Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.
    Wang Y; Taroni F; Garavaglia B; Longo N
    Hum Mutat; 2000 Nov; 16(5):401-7. PubMed ID: 11058897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality.
    Burwinkel B; Kreuder J; Schweitzer S; Vorgerd M; Gempel K; Gerbitz KD; Kilimann MW
    Biochem Biophys Res Commun; 1999 Aug; 261(2):484-7. PubMed ID: 10425211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
    Lamhonwah AM; Olpin SE; Pollitt RJ; Vianey-Saban C; Divry P; Guffon N; Besley GT; Onizuka R; De Meirleir LJ; Cvitanovic-Sojat L; Baric I; Dionisi-Vici C; Fumic K; Maradin M; Tein I
    Am J Med Genet; 2002 Aug; 111(3):271-84. PubMed ID: 12210323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene.
    Lamhonwah AM; Tein I
    Biochem Biophys Res Commun; 1998 Nov; 252(2):396-401. PubMed ID: 9826541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients.
    Tang NL; Hwu WL; Chan RT; Law LK; Fung LM; Zhang WM
    Hum Mutat; 2002 Sep; 20(3):232. PubMed ID: 12204000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
    Wang Y; Ye J; Ganapathy V; Longo N
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.
    Dobrowolski SF; McKinney JT; Amat di San Filippo C; Giak Sim K; Wilcken B; Longo N
    Hum Mutat; 2005 Mar; 25(3):306-13. PubMed ID: 15714519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFP-Human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with the carnitine transporter defect.
    Lamhonwah AM; Tein I
    Biochem Biophys Res Commun; 1999 Nov; 264(3):909-14. PubMed ID: 10544029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency.
    Li FY; El-Hattab AW; Bawle EV; Boles RG; Schmitt ES; Scaglia F; Wong LJ
    Hum Mutat; 2010 Aug; 31(8):E1632-51. PubMed ID: 20574985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
    Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
    Amat di San Filippo C; Pasquali M; Longo N
    Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse.
    Lu Km; Nishimori H; Nakamura Y; Shima K; Kuwajima M
    Biochem Biophys Res Commun; 1998 Nov; 252(3):590-4. PubMed ID: 9837751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
    Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
    Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.